Snyder Mark Howard Insider Trades & Stock Holdings

SVP, CHIEF LEGAL OFFICER · Halozyme Therapeutics, Inc. · Latest filing Jun 12, 2026

Snyder Mark Howard, SVP, CHIEF LEGAL OFFICER at Halozyme Therapeutics, Inc. has 2 Form 4 trades on file since Jun 12, 2026. Latest filing: disposed of 5.03K shares of $HALO on Jun 12, 2026.

Trades on file: 2
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 12, 2026

All insider trades by Snyder Mark Howard

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 12, 2026	$HALO	Sell (Option exercise)	5.03K	$0	—			-0.7%	+9.5%		SVP, CHIEF LEGAL OFFICER		—
Jun 12, 2026	$HALO	Buy (Option exercise)	5.03K	$0	—			-0.7%	+9.5%		SVP, CHIEF LEGAL OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Snyder Mark Howard traded

$HALO

Frequently asked questions

What was Snyder Mark Howard's latest insider trade?

disposed of 5.03K shares of $HALO on Jun 12, 2026.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text